SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 24 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $0 | -100.0% | 804 | +2.8% | 0.00% | – |
Q2 2019 | $1,000 | -88.9% | 782 | -80.1% | 0.00% | – |
Q1 2019 | $9,000 | -79.5% | 3,939 | -79.4% | 0.00% | – |
Q4 2018 | $44,000 | -77.8% | 19,082 | +42.8% | 0.00% | – |
Q3 2018 | $198,000 | +36.6% | 13,362 | +40.2% | 0.00% | – |
Q2 2018 | $145,000 | +62.9% | 9,531 | +101.0% | 0.00% | – |
Q1 2018 | $89,000 | +39.1% | 4,741 | +34.8% | 0.00% | – |
Q4 2017 | $64,000 | +68.4% | 3,516 | +106.8% | 0.00% | – |
Q3 2017 | $38,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 758,610 | $1,760,000 | 1.30% |
Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.45% |
PFM Health Sciences, LP | 1,576,619 | $3,658,000 | 0.10% |
Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.07% |
Partner Investment Management, L.P. | 15,283 | $35,000 | 0.04% |
CLOUGH CAPITAL PARTNERS L P | 136,228 | $316,000 | 0.04% |
Tower Research Capital LLC (TRC) | 12,183 | $29,000 | 0.00% |
Assenagon Asset Management S.A. | 69,931 | $162,000 | 0.00% |
Ballentine Partners, LLC | 16,700 | $39,000 | 0.00% |
A.R.T. Advisors, LLC | 10,206 | $24,000 | 0.00% |